David Goldenberg

10.4k total citations · 1 hit paper
245 papers, 7.2k citations indexed

About

David Goldenberg is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David Goldenberg has authored 245 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Surgery, 66 papers in Pulmonary and Respiratory Medicine and 57 papers in Oncology. Recurrent topics in David Goldenberg's work include Thyroid Cancer Diagnosis and Treatment (51 papers), Tracheal and airway disorders (40 papers) and Head and Neck Cancer Studies (37 papers). David Goldenberg is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (51 papers), Tracheal and airway disorders (40 papers) and Head and Neck Cancer Studies (37 papers). David Goldenberg collaborates with scholars based in United States, Israel and United Kingdom. David Goldenberg's co-authors include James J. Sciubba, William A. Weiss, Henry Z. Joachims, Avishay Golz, Wayne M. Koch, Kevan M. Shokat, David Stokoe, Zachary A. Knight, David Sidransky and Aviram Netzer and has published in prestigious journals such as Cell, PLoS ONE and Cancer Cell.

In The Last Decade

David Goldenberg

235 papers receiving 7.0k citations

Hit Papers

A Pharmacological Map of ... 2006 2026 2012 2019 2006 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Goldenberg 2.2k 2.2k 1.6k 1.4k 1.3k 245 7.2k
Luciano Giacomelli 1.5k 0.7× 2.2k 1.0× 1.4k 0.8× 986 0.7× 753 0.6× 247 6.7k
Terry A. Day 1.7k 0.8× 2.5k 1.2× 2.4k 1.5× 1.6k 1.1× 2.9k 2.2× 188 7.8k
Satoshi Teramukai 1.1k 0.5× 2.5k 1.1× 2.4k 1.5× 2.0k 1.4× 163 0.1× 372 9.8k
Søren Friis 1.1k 0.5× 1.9k 0.9× 1.6k 1.0× 1.2k 0.9× 248 0.2× 204 6.6k
Loretta M. Itri 3.5k 1.6× 1.2k 0.6× 4.0k 2.5× 1.5k 1.0× 533 0.4× 91 10.9k
Lennart Friis‐Hansen 1.8k 0.8× 1.1k 0.5× 715 0.4× 709 0.5× 262 0.2× 149 4.6k
Mitsuyoshi Urashima 2.5k 1.1× 1.2k 0.5× 1.9k 1.2× 1.3k 0.9× 121 0.1× 222 8.7k
Nabil F. Saba 2.5k 1.1× 2.6k 1.2× 4.1k 2.6× 2.5k 1.7× 3.1k 2.4× 406 9.2k
Dora L.�W. Kwong 3.3k 1.5× 3.5k 1.6× 3.4k 2.1× 3.0k 2.2× 4.1k 3.1× 219 11.1k
David Rosen 1.9k 0.9× 865 0.4× 923 0.6× 449 0.3× 176 0.1× 124 5.0k

Countries citing papers authored by David Goldenberg

Since Specialization
Citations

This map shows the geographic impact of David Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Goldenberg more than expected).

Fields of papers citing papers by David Goldenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Goldenberg. The network helps show where David Goldenberg may publish in the future.

Co-authorship network of co-authors of David Goldenberg

This figure shows the co-authorship network connecting the top 25 collaborators of David Goldenberg. A scholar is included among the top collaborators of David Goldenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Goldenberg. David Goldenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goyal, Neerav, et al.. (2025). Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy. Otolaryngology. 172(4). 1192–1198. 1 indexed citations
2.
Schneper, Lisa, Kathryn Sheldon, César Aliaga, et al.. (2024). Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes. Molecular Cancer Research. 23(2). 119–127. 1 indexed citations
3.
Goyal, Neerav, et al.. (2024). Evolution of the Neck Dissection. Operative Techniques in Otolaryngology-Head and Neck Surgery. 35(4). 290–296. 1 indexed citations
5.
Goldenberg, David, et al.. (2023). Opioid versus non-opioid postoperative pain management in otolaryngology. BMC Anesthesiology. 23(1). 291–291. 2 indexed citations
6.
Alam, Samina, et al.. (2022). Assessing nonsexual transmission of the human papillomavirus (HPV): Do our current cleaning methods work?. Journal of Medical Virology. 94(8). 3956–3961.
8.
Wilson, Robin Taylor, et al.. (2022). What have we learned about health effects more than 40 years after the Three Mile Island nuclear accident? A scoping and process review. Risk Hazards & Crisis in Public Policy. 14(2). 129–158. 1 indexed citations
9.
Zhang, Lijun, et al.. (2022). Human Papillomavirus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer. Molecular Cancer Research. 20(9). 1420–1428. 17 indexed citations
10.
Manni, Andrea, et al.. (2022). Analysis of Time to Diagnosis and Outcomes Among Adults With Primary Hyperparathyroidism. JAMA Network Open. 5(12). e2248332–e2248332. 14 indexed citations
11.
Sataloff, Robert T., Matthew L. Bush, Rakesh Chandra, et al.. (2021). Systematic and other reviews: Criteria and complexities. Head & Neck. 43(7). 1979–1982. 1 indexed citations
12.
Bann, Darrin V., Kathryn Sheldon, Lan Nguyễn, et al.. (2019). Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer. Cancer Research. 79(21). 5490–5499. 20 indexed citations
13.
Saadi, Robert, et al.. (2018). Using Technology in Global Otolaryngology. Otolaryngologic Clinics of North America. 51(3). 555–561. 9 indexed citations
14.
Abdulghani, Junaid, Jean‐Nicolas Gallant, David T. Dicker, et al.. (2016). Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). Clinical Cancer Research. 22(24). 6192–6203. 35 indexed citations
15.
Goldenberg, David, et al.. (2012). Recurrent Differentiated Thyroid Cancer. 2(3). 73–80. 32 indexed citations
16.
Carvalho, André Lopes, Rui Henrique, Cármen Jerónimo, et al.. (2011). Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance. Clinical Cancer Research. 17(14). 4782–4789. 70 indexed citations
17.
Govindan, Serengulam V., Thomas M. Cardillo, Sung-Ju Moon, & David Goldenberg. (2009). Abstract #3233: Targeted therapy of human colonic, lung, and pancreatic cancer xenografts, growing in nude mice, with potent antibody conjugates of SN-38. Cancer Research. 69. 3233–3233. 1 indexed citations
18.
Chang, Chien‐Hsing, et al.. (2008). A modular method to prepare novel tetrameric cytokines, IFN, G-CSF, and EPO, with improved pharmacokinetics by the Dock-and-Lock (DNL) platform technology. Cancer Research. 68. 4906–4906. 2 indexed citations
19.
Chesler, Louis, David Goldenberg, Ronit Satchi‐Fainaro, et al.. (2007). Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma. Cancer Research. 67(19). 9435–9442. 54 indexed citations
20.
Hong, Chibo, Alika K. Maunakea, Peter Jun, et al.. (2005). Shared Epigenetic Mechanisms in Human and Mouse Gliomas Inactivate Expression of the Growth Suppressor SLC5A8. Cancer Research. 65(9). 3617–3623. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026